Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001789335-26-000004

Director acquired 3,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Chan Mitchell · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-28 Exercise or conversion : show line 1 in the form +3,166 6,333 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-28 Exercise or conversion : show line 2 in the form Restricted Stock Units −3,166 3,167 D
Loading xslF345X06/form4-03312026_080349.xml…